Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03733730 · ClinicalTrials.gov registry record · NA
Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 2,449
- Enrollment target
NCT03733730 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 2,449 participants.
The verdict
NCT03733730, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,449 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, post-approval active surveillance study. The purpose of this study is to report the rate of post-surgical intraocular inflammation (based upon a specified case definition) reported within a 180-day post-surgical period following attempted implantation of an ACRYSOF IQ RESTOR Toric or ACRYSOF IQ RESTOR IOL in the US.
Interventions
- PROCEDURE Cataract Surgery
- DEVICE ACRYSOF IQ RESTOR +3.0 Multifocal Toric IOL
- DEVICE ACRYSOF IQ RESTOR +2.5 D Multifocal Toric IOL
- DEVICE ACRYSOF IQ RESTOR +2.5 D Multifocal IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,449 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2022-10-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03733730
The ClinicalTrials.gov registry entry for NCT03733730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,449 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cataract Surgery is the first listed.
NCT03733730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03733730 about?
NCT03733730 is a clinical study titled "Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs". This is a prospective, multicenter, post-approval active surveillance study. The purpose of this study is to report the rate of post-surgical intraocular inflammation (based upon a specified case definition) reported within a 180-day post-surgical period following attempted implantation of an ACRYSO...
What is the current status of trial NCT03733730?
This trial is currently completed. It is a NA study. The enrollment target is 2,449 participants. The study started on 2018-11-27. Estimated completion is 2022-10-14.
What interventions are being tested in trial NCT03733730?
The interventions under investigation include: Cataract Surgery (PROCEDURE), ACRYSOF IQ RESTOR +3.0 Multifocal Toric IOL (DEVICE), ACRYSOF IQ RESTOR +2.5 D Multifocal Toric IOL (DEVICE), ACRYSOF IQ RESTOR +2.5 D Multifocal IOL (DEVICE).
Who is sponsoring clinical trial NCT03733730?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.